Surgical management of obstructing clot at the jejunojejunostomy after gastric bypass: a single center experience and literature review
- PMID: 33414097
- DOI: 10.1016/j.soard.2020.11.020
Surgical management of obstructing clot at the jejunojejunostomy after gastric bypass: a single center experience and literature review
Abstract
Background: Roux-en-Y gastric bypass is a proven treatment for morbid obesity and its sequelae. Gastric bypass has a safe risk profile, but postoperative complications can be seen. We report on 10 cases of postoperative bleeding causing an obstructing clot at the jejunojejunostomy (JJ) occurring over a 9-year period.
Objectives: The aim was to document presenting symptoms of obstructing clots at the JJ and to suggest a treatment approach to minimize complications.
Setting: University Hospital, United States METHODS: The local Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database was queried for all patients undergoing reoperation after Roux-en-Y gastric bypass, from July 2009 until December 2019. All patients who were found to have postoperative bleeding causing an obstructing clot at the JJ were selected for retrospective medical-record review.
Results: The most common presenting symptoms were Hematocrit drop (10 of 10), nausea (9 of 10), abdominal pain (7 of 10), and hematemesis (4 of 10). There were 12 reoperations in the 10 patients, 10 of which were completed laparoscopically. Infectious complications were the most frequent morbidity in our patients; 4 patients developed abscesses. In all of these, the operative notes described gross spillage into the peritoneal cavity. In later cases, the remnant stomach was decompressed before reoperation, reducing spillage.
Conclusions: Despite the low rate of obstructing clots at the JJ, without rapid recognition and reoperation, there is a risk for serious complications. Typical presenting symptoms include nausea and abdominal pain, which help differentiate it from other causes of decreased hematocrit. Diagnosis is commonly made with computerized tomographic (CT) scan. Decompression of a dilated remnant stomach before addressing the clot can prevent intraperitoneal spillage and subsequent abscess formation. Enterotomy creation and removal of clot is recommended, without fear of continued bleeding.
Keywords: Gastric bypass; Intraluminal clot; Jejunojejunostomy; Obstruction; Postoperative complications.
Copyright © 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Blood clot obstruction of the jejunojejunostomy after laparoscopic gastric bypass.Surg Obes Relat Dis. 2013 Mar-Apr;9(2):234-7. doi: 10.1016/j.soard.2011.12.014. Epub 2012 Feb 2. Surg Obes Relat Dis. 2013. PMID: 22421098
-
Acute, complete proximal small bowel obstruction after laparoscopic gastric bypass due to intraluminal blood clot formation.Surg Obes Relat Dis. 2005 Jul-Aug;1(4):418-22; discussion 422-3. doi: 10.1016/j.soard.2005.04.004. Epub 2005 Jun 14. Surg Obes Relat Dis. 2005. PMID: 16925262
-
Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass.Surg Obes Relat Dis. 2013 Sep-Oct;9(5):718-24. doi: 10.1016/j.soard.2012.05.009. Epub 2012 Jun 21. Surg Obes Relat Dis. 2013. PMID: 22796431
-
Small Bowel Obstruction After Laparoscopic Roux-en-Y Gastric Bypass Caused by Hemobezoar: A Case Series and Review of Literature.Surg Laparosc Endosc Percutan Tech. 2021 Jun 7;31(5):618-623. doi: 10.1097/SLE.0000000000000963. Surg Laparosc Endosc Percutan Tech. 2021. PMID: 34091483 Review.
-
[Surgery for morbid obesity: 2. Complications. Results of a Technologic Evaluation by the ANAES].J Chir (Paris). 2003 Feb;140(1):4-21. J Chir (Paris). 2003. PMID: 12709648 Review. French.
Cited by
-
Early Bleeding After Laparoscopic Roux-en-Y Gastric Bypass: Incidence, Risk Factors, and Management - a 21-Year Experience.Obes Surg. 2022 Oct;32(10):3232-3238. doi: 10.1007/s11695-022-06173-y. Epub 2022 Aug 6. Obes Surg. 2022. PMID: 35932414 Free PMC article.
-
Circular RNA mitochondrial translation optimization 1 correlates with less lymph node metastasis, longer disease-free survival, and higher chemotherapy sensitivity in gastric cancer.J Clin Lab Anal. 2022 Jun;36(6):e23918. doi: 10.1002/jcla.23918. Epub 2022 Apr 27. J Clin Lab Anal. 2022. PMID: 35478417 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials